Production (Stage)
MedX Health Corp
MDX.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 356.10K | 270.60K | 287.10K | 381.90K | 339.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 356.10K | 270.60K | 287.10K | 381.90K | 339.10K |
| Cost of Revenue | 215.00K | 180.10K | 172.70K | 232.70K | 199.70K |
| Gross Profit | 141.20K | 90.40K | 114.30K | 149.10K | 139.20K |
| SG&A Expenses | 1.44M | 1.63M | 1.92M | 2.00M | 2.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.04M | 2.19M | 2.47M | 2.61M | 2.58M |
| Operating Income | -1.69M | -1.92M | -2.18M | -2.23M | -2.24M |
| Income Before Tax | -2.66M | -2.32M | -2.83M | -3.18M | -3.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.66 | -2.32 | -2.83 | -3.18 | -3.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.66M | -2.32M | -2.83M | -3.18M | -3.40M |
| EBIT | -1.69M | -1.92M | -2.18M | -2.23M | -2.24M |
| EBITDA | -1.67M | -1.89M | -2.16M | -2.21M | -2.21M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.07B | 1.03B | 947.09M | 866.58M | 788.37M |
| Average Diluted Shares Outstanding | 1.07B | 1.03B | 947.09M | 866.58M | 788.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |